Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".
作者信息
Sindelar Morganne, McCabe Daniel, Carroll Elisabeth
机构信息
The University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
Division of Medical Toxicology, Department of Emergency Medicine, The University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
出版信息
J Med Toxicol. 2023 Jul;19(3):309. doi: 10.1007/s13181-023-00940-8. Epub 2023 Mar 29.
Abstract
摘要
相似文献
1
Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".对关于“他克莫司与奈玛特韦/利托那韦（帕罗韦德™）药物相互作用通过苯妥英处理”评论的回复
J Med Toxicol. 2023 Jul;19(3):309. doi: 10.1007/s13181-023-00940-8. Epub 2023 Mar 29.
2
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.他克莫司与奈玛特韦/利托那韦（帕克洛维）的药物相互作用，并用苯妥英管理。
J Med Toxicol. 2023 Jan;19(1):45-48. doi: 10.1007/s13181-022-00922-2. Epub 2022 Dec 19.
3
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin".关于“他克莫司与奈玛特韦/利托那韦（帕罗韦德™）的药物相互作用及苯妥英钠的处理”的评论
J Med Toxicol. 2023 Jul;19(3):307-308. doi: 10.1007/s13181-023-00936-4. Epub 2023 Mar 29.
4
Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion.药物相互作用导致他克莫司血药浓度高于治疗范围，用苯妥英诱导酶代谢进行治疗：病例系列及讨论。
Am J Health Syst Pharm. 2024 Jun 24;81(13):e345-e352. doi: 10.1093/ajhp/zxae032.
5
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).新冠病毒感染者中奈玛特韦/利托那韦药物相互作用的管理：法国药理学和治疗学学会（SFPT）指南。
Therapie. 2022 Sep-Oct;77(5):509-521. doi: 10.1016/j.therap.2022.03.005. Epub 2022 Apr 20.
6
Elevated tacrolimus levels after treatment with nirmatrelvir/ritonavir (Paxlovid) for COVID-19 infection in a child with a kidney transplant.COVID-19 感染患儿在使用奈玛特韦/利托那韦（Paxlovid）治疗后，他的他克莫司水平升高。
Pediatr Nephrol. 2023 Apr;38(4):1387-1388. doi: 10.1007/s00467-022-05712-0. Epub 2022 Aug 19.
7
Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients - a case series with four patients.尼马曲韦/利托那韦治疗 SARS-CoV-2 阳性肾移植受者 - 四例病例系列。
BMC Nephrol. 2023 Apr 15;24(1):99. doi: 10.1186/s12882-023-03154-w.
8
Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.尼马瑞韦/利托那韦联合他克莫司用于肺移植受者：一项单中心病例系列研究。
Transplantation. 2023 May 1;107(5):1200-1205. doi: 10.1097/TP.0000000000004394. Epub 2022 Oct 28.
9
A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis.一名接受伊曲康唑预防治疗的肺移植受者，因同时服用奈玛特韦/利托那韦导致他克莫司清除率长期下降的病例报告。
J Pharm Health Care Sci. 2023 Apr 1;9(1):12. doi: 10.1186/s40780-023-00280-3.
10
Tacrolimus toxicity due to enzyme inhibition from ritonavir.因利托那韦的酶抑制作用导致他克莫司中毒。
Am J Emerg Med. 2023 Jul;69:218.e5-218.e7. doi: 10.1016/j.ajem.2023.04.045. Epub 2023 May 5.
本文引用的文献
1
Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin.他克莫司与奈玛特韦/利托那韦（帕克洛维）的药物相互作用，并用苯妥英管理。
J Med Toxicol. 2023 Jan;19(1):45-48. doi: 10.1007/s13181-022-00922-2. Epub 2022 Dec 19.
Zotero 插件